These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. MexXY multidrug efflux system of Pseudomonas aeruginosa. Morita Y, Tomida J, Kawamura Y. Front Microbiol; 2012; 3():408. PubMed ID: 23233851 [Abstract] [Full Text] [Related]
9. Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon. Morita Y, Tomida J, Kawamura Y. Front Microbiol; 2015; 6():8. PubMed ID: 25653649 [Abstract] [Full Text] [Related]
10. Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Vogne C, Aires JR, Bailly C, Hocquet D, Plésiat P. Antimicrob Agents Chemother; 2004 May; 48(5):1676-80. PubMed ID: 15105120 [Abstract] [Full Text] [Related]
11. MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa. Mao W, Warren MS, Lee A, Mistry A, Lomovskaya O. Antimicrob Agents Chemother; 2001 Jul; 45(7):2001-7. PubMed ID: 11408215 [Abstract] [Full Text] [Related]